Clearmind Medicine Inc
CMND2.120USD
-0.110-4.93%
Market hours （ET）Quotes delayed by 15 min
335.12KMarket Cap
0.00P/E TTM
More Details of Clearmind Medicine Inc Company
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc Info
Ticker SymbolCMND
Company nameClearmind Medicine Inc
IPO dateAug 10, 2021
CEOZuloff-Shani (Adi)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 10
Address101-1220 West 6Th Avenue
CityVANCOUVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeV6H 1A5
Phone16042601566
Websitehttps://www.clearmindmedicine.com/
Ticker SymbolCMND
IPO dateAug 10, 2021
CEOZuloff-Shani (Adi)
Company Executives of Clearmind Medicine Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
4.62K
+3621.00%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
1.87K
+1874.00%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
935.00
+935.00%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
713.00
+93.00%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-3.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
4.62K
+3621.00%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
1.87K
+1874.00%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
935.00
+935.00%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
713.00
+93.00%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-3.00%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Jan 25
Updated: Sun, Jan 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Capitalink Ltd.
9.97%
L.I.A. Pure Capital Ltd
9.97%
Daniel (Nissim)
5.51%
AdvisorShares Investments, LLC
0.37%
Shani (Adi Zuloff)
0.31%
Other
73.87%
Shareholders
Shareholders
Proportion
Capitalink Ltd.
9.97%
L.I.A. Pure Capital Ltd
9.97%
Daniel (Nissim)
5.51%
AdvisorShares Investments, LLC
0.37%
Shani (Adi Zuloff)
0.31%
Other
73.87%
Shareholder Types
Shareholders
Proportion
Corporation
19.94%
Individual Investor
6.43%
Investment Advisor
0.42%
Research Firm
0.05%
Other
73.17%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
18
281.13K
2.83%
--
2025Q3
20
281.13K
17.81%
-308.29K
2025Q2
21
589.42K
18.96%
-12.36K
2025Q1
18
601.77K
18.55%
-350.88K
2024Q4
18
612.80K
20.27%
-89.61K
2024Q3
17
702.42K
8.27%
+411.62K
2024Q2
15
290.80K
5.30%
+12.32K
2024Q1
15
281.81K
3.72%
+163.87K
2023Q4
13
96.03K
1.96%
+64.13K
2023Q3
13
31.90K
2.51%
+20.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Capitalink Ltd.
149.51K
9.97%
+66.83K
+80.83%
Dec 03, 2025
L.I.A. Pure Capital Ltd
149.51K
9.97%
+66.83K
+80.83%
Dec 03, 2025
Daniel (Nissim)
82.68K
5.51%
+82.68K
--
Nov 19, 2025
AdvisorShares Investments, LLC
5.61K
0.37%
+461.00
+8.95%
Sep 30, 2025
Shani (Adi Zuloff)
1.36K
0.09%
+1.31K
+3128.57%
Oct 31, 2024
Weiss (Amitay)
996.00
0.07%
--
--
Nov 20, 2025
Shachar (Yehonatan Samuel)
312.00
0.02%
--
--
Nov 20, 2025
Virtu Americas LLC
714.00
0.05%
+714.00
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AdvisorShares Psychedelics ETF
1.16%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
Proportion1.16%
Fidelity Nasdaq Composite Index ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Dec 11, 2025
Merger
40→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Dec 11, 2025
Merger
40→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
